Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Sio Capital Management, LLC (CIK 1482416) reported $697.3M across 71 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: MMS ($49.3M, 7.07%), WAY ($39.6M, 5.68%), ICLR ($33.9M, 4.86%), ABC ($31.7M, 4.55%), DNTH ($31.1M, 4.45%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MMS | MAXIMUS INC | $49.3M | 7.07% | 768,825 | Added |
| 2 | WAY | WAYSTAR HLDG CORP | $39.6M | 5.68% | 1.6M | Added |
| 3 | ICLR | ICON PLC | $33.9M | 4.86% | 306,358 | Added |
| 4 | ABC | CENCORA INC | $31.7M | 4.55% | 100,894 | Added |
| 5 | DNTH | DIANTHUS THERAPEUTICS INC | $31.1M | 4.45% | 370,045 | Trimmed |
| 6 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $29.9M | 4.28% | 5.4M | Added |
| 7 | CORT | CORCEPT THERAPEUTICS INC | $27.2M | 3.90% | 674,759 | New |
| 8 | LIVN | LIVANOVA PLC | $26.8M | 3.84% | 421,615 | Added |
| 9 | TYRA | TYRA BIOSCIENCES INC | $23.2M | 3.33% | 605,439 | Added |
| 10 | CELC | CELCUITY INC | $22.1M | 3.17% | 193,843 | Trimmed |
| 11 | GSK | GSK PLC | $21.3M | 3.05% | 385,879 | New |
| 12 | ANIP | ANI PHARMACEUTICALS INC | $20.4M | 2.93% | 265,543 | Added |
| 13 | ABT | ABBOTT LABORATORIES | $19.2M | 2.75% | 186,574 | New |
| 14 | EMBC | EMBECTA CORP | $16.3M | 2.34% | 1.8M | New |
| 15 | ABVX | ABIVAX SA | $15.1M | 2.17% | 135,800 | Added |
| 16 | VIR | VIR BIOTECHNOLOGY INC | $13.4M | 1.93% | 1.5M | Added |
| 17 | HAE | HAEMONETICS CORP MASS | $12.4M | 1.78% | 220,672 | Added |
| 18 | SION | SIONNA THERAPEUTICS INC | $11.8M | 1.69% | 294,340 | New |
| 19 | SNY | SANOFI SA | $11.5M | 1.66% | 239,671 | Trimmed |
| 20 | RAPP | RAPPORT THERAPEUTICS INC | $11.5M | 1.65% | 366,809 | Added |
| 21 | TFX | TELEFLEX INCORPORATED | $11.3M | 1.63% | 94,800 | Added |
| 22 | BMRN | BIOMARIN PHARMACEUTICAL INC | $11.0M | 1.57% | 194,226 | Trimmed |
| 23 | CCRN | CROSS CTRY HEALTHCARE INC | $10.3M | 1.48% | 1.1M | Added |
| 24 | TARA | PROTARA THERAPEUTICS INC | $10.3M | 1.47% | 2.0M | Added |
| 25 | GPCR | STRUCTURE THERAPEUTICS INC | $10.1M | 1.45% | 209,093 | Added |
Source: SEC Form 13F filings · as of 2026-03-31